UCSD rheumatologist Dr. Gary S. Firestein is featured in a New York Times profile on current treatment and future research directions for rheumatoid arthritis.
Published in the New York Times Health Guide, the profile describes Dr. Firestein’s pioneering work in the use of tumor necrosis factor (TNF) blockers to treat rheumatoid arthritis.
Gary S. Firestein, M.D., is Professor of Medicine, Chief of the Division of Rheumatology, Allergy and Immunology and Dean of Translational Medicine at UCSD.
Read the New York Times article
More Information:
- Division of Rheumatology, Allergy & Immunology
- Dr. Gary Firestein:
